Cend Therapeutics Announces Acquisition of Impilo Therapeutics
Cend Therapeutics, Inc., a clinical-stage biotech company, announced that it has acquired Impilo Therapeutics, Inc. The combination expands Cend’s drug delivery capabilities to create a…
Read More...
Read More...
